The purpose of this review is to analyze approaches to the treatment of depressive and
negative disorders in schizophrenia in terms of their level of efficacy and safety. Materials …

Background. Depression is common in people with schizophrenia and is associated with
substantial morbidity and an increased risk of suicide. Our aim was to review systematically …

We focused on the application of antidepressants in schizophrenia treatment in this review.
Augmentation of antidepressants with antipsychotics is a common clinical practice to treat …

Objective: The authors examined the safety and efficacy of antidepressants added to
antipsychotic drugs in the treatment of schizophrenia. Method: Multiple databases and …

The aim of our meta-analysis was to review the evidence base for the efficacy and safety of
antipsychotic and antidepressant combinations in the treatment of the negative symptoms of …

Depressive symptoms during schizophrenic psychosis represent an important part of the
overall spectrum of psycho-pathological symptoms, not only in the schizoaffective type but …

Background Depressive symptoms, often of substantial severity, are found in 50% of newly
diagnosed suffers of schizophrenia and 33% of people with chronic schizophrenia who have …

Depression is a common comorbid syndrome in patients with schizophrenia. A review of the
literature highlights the multitude of different expressions used to describe depression in this …

BackgroundTreatment of negative symptoms in chronic schizophrenia continues to be a
major clinical issue. AimsTo analyse the efficacy of add-on antidepressants for the treatment …

Schizophrenia treatment is challenging. We have no resolutive treatments, available
medications at best offer a variable degree of control over the psychiatric symptomatology to …